Gravie, the pioneer of defined contribution healthcare, has completed a $28 million Series D round of financing led by AXA Venture Partners (AVP), with participation from existing investors FirstMark Capital, Split Rock Ventures and Revelation Partners. The capital will be used to fuel Gravie’s continued growth through investments in product and technology, sales and marketing, and expansion into new markets through new and existing distribution channels.
“We are excited to partner with AXA Venture Partners in our mission to heal our broken healthcare system,” said Abir Sen, co-founder and Executive Chairman of Gravie. “Over the past couple of years, we have grown revenue four-fold, expanded into several new states, grown our marketplace of benefits including our own innovative insurance plan, Comfort, and most importantly, done all this while consistently getting top satisfaction ratings from employers and their employees. This financing will enable us to continue to scale the business and deliver an innovative approach to health benefits to employers and consumers across the country.”
“Gravie is revolutionizing how businesses and their employees access the healthcare system,” said Alex Scherbakovsky, AVP General Partner. “We are proud to partner with Abir and the Gravie team to scale the company.”
Gravie has been designing benefits solutions that put employers’ and employees’ needs at the center of the healthcare ecosystem. With Gravie’s defined contribution approach, employers are able to set and stick to a benefits budget that works for their business, and employees are free to choose the out-of-pocket maximum that works for them.
AXA Venture Partners (AVP) is a global venture capital firm investing in high-growth, technology-enabled companies. AVP has built, in less than five years, a unique investment platform specialized in tech investments with $1 billion of assets under management through three pillars of investment expertise: early stage, growth stage, and fund of funds.